<SEC-DOCUMENT>0001213900-21-034344-index.html : 20210628 <SEC-HEADER>0001213900-21-034344.hdr.sgml : 20210628 <ACCEPTANCE-DATETIME>20210628091810 ACCESSION NUMBER: 0001213900-21-034344 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20210613 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210628 DATE AS OF CHANGE: 20210628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avalon GloboCare Corp. CENTRAL INDEX KEY: 0001630212 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 471685128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-38728 FILM NUMBER: 211050247 BUSINESS ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 BUSINESS PHONE: (646) 762-4517 MAIL ADDRESS: STREET 1: 4400 ROUTE 9 STREET 2: SUITE 3100 CITY: FREEHOLD STATE: NJ ZIP: 07728 FORMER COMPANY: FORMER CONFORMED NAME: Avalon Globocare Corp. DATE OF NAME CHANGE: 20161018 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL TECHNOLOGIES CORP DATE OF NAME CHANGE: 20150108 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>ea143147-8ka1_avalonglob.htm <DESCRIPTION>AMENDMENT NO. 1 TO FORM 8-K <TEXT> Document 1 - file: ea143147-8ka1_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>2 <FILENAME>ea143147ex10-2_avalonglob.htm <DESCRIPTION>AMENDMENT NO. 1 TO SECURITIES EXCHANGE AGREEMENT, DATED JUNE 24, 2021, AMONG AVALON GLOBOCARE CORP, LONLON BIOTECH LTD., SENLANG BIOTECHNOLOGY CO. LTD. AND YUEYIN DATONG (TIANJIN) ASSET MANAGEMENT CO. LTD. <TEXT> Document 2 - file: ea143147ex10-2_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ea143147ex23-1_avalonglob.htm <DESCRIPTION>CONSENT OF FRIEDMAN LLP. <TEXT> Document 3 - file: ea143147ex23-1_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>ea143147ex99-2_avalonglob.htm <DESCRIPTION>SEN LANG'S AUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2020, AND THE NOTES RELATED THERETO <TEXT> Document 4 - file: ea143147ex99-2_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>5 <FILENAME>ea143147ex99-3_avalonglob.htm <DESCRIPTION>SEN LANG'S UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE QUARTER ENDED MARCH 31, 2021, AND THE NOTES RELATED THERETO <TEXT> Document 5 - file: ea143147ex99-3_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>6 <FILENAME>ea143147ex99-4_avalonglob.htm <DESCRIPTION>THE COMPANY'S UNAUDITED PRO FORMA CONSOLIDATED COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEAR ENDED DECEMBER 31, 2020 AND THE THREE MONTHS ENDED MARCH 31, 2021, THE UNAUDITED PRO FORMA CONSOLIDATED COMBINED BALANCE SHEET AS OF MARCH <TEXT> Document 6 - file: ea143147ex99-4_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.5 <SEQUENCE>7 <FILENAME>ea143147ex99-5_avalonglob.htm <DESCRIPTION>PRESS RELEASE DATED JUNE 28, 2021 <TEXT> Document 7 - file: ea143147ex99-5_avalonglob.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>ex23-1_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: ex23-1_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>9 <FILENAME>ex99-2_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 9 - file: ex99-2_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>10 <FILENAME>ex99-3_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 10 - file: ex99-3_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>11 <FILENAME>ex99-5_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 11 - file: ex99-5_001.jpg
</DOCUMENT> </SEC-DOCUMENT>